Cypher® sirolimus-eluting coronary stent comparable to bypass surgery in key safety measures in patients with diabetes and multi-vessel disease

Data from the largest randomized trial of its kind performed to date indicate that the use of percutaneous coronary intervention (PCI) with the CYPHER® Sirolimus-eluting Coronary Stent was comparable to bypass surgery (coronary artery bypass grafting or CABG) in key safety endpoints in patients with multi-vessel disease and diabetes. (Source: Health News from Medical News Today)

 

: Find out how you can get your across here by sponsoring this news feed.